default author photo

Pål Aukrust

University of Oslo - Institute of Clinical Medicine

Kirkeveien 166

Building 2H

Oslo, N-0450

Norway

SCHOLARLY PAPERS

2

DOWNLOADS

415

TOTAL CITATIONS

7

Scholarly Papers (2)

1.

Evaluation of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 Patients: Results from the NOR-Solidarity Randomised Trial

Number of pages: 33 Posted: 11 Feb 2021
University of Oslo - Division of Emergencies and Critical Care, University of Oslo - Department of Research Support for Clinical Trials, University of Oslo - Oslo University Hospital, University of Oslo - Division of Emergencies and Critical Care, University of Oslo - Department of Immunology and Transfusion Medicine, University of Oslo - Institute of Clinical Medicine, University of Oslo - Institute of Clinical Medicine, Vestre Viken Hospital Trust, Diakonhjemmet Hospital, Sørlandet Hospital, Innlandet Hospital, University Hospital North Norway, University of Stavanger - Stavanger University Hospital, University of Oslo - Institute of Clinical Medicine, Vestre Viken Hospital Trust, University of Oslo - Division of Emergencies and Critical Care, University of Oslo - Oslo University Hospital, District General Hospital of Førde - Section for Rheumatology, Haugesund Hospital, Vestre Viken Hospital Trust, Vestre Viken Hospital Trust, Møre og Romsdal Hospital Trust, Telemark Hospital Trust, Haraldsplass Deaconess Hospital, Sørlandet Hospital, Møre & Romsdal Hospital Trust - Molde Hospital - 8Department of Internal Medicine, Innlandet Hospital Trust, Nord-Trøndelag Hospital Trust, University of Oslo - Department of Immunology and Transfusion Medicine, University of Oslo - Institute of Clinical Medicine, University of Oslo - Department of Immunology and Transfusion Medicine, Trondheim University Hospital, Akershus University Hospital - Department of Infectious Diseases, Lovisenberg Diaconal Hospital - Department of Medicine, University of Oslo - Institute of Clinical Medicine, University of Bergen - Department of Clinical Science, Østfold Hospital Kalnes - Department of Infectious Diseases, University of Oslo - Oslo University Hospital, University of Oslo - Institute of Clinical Medicine, University of Oslo - Institute of Clinical Medicine, University of Oslo - Institute of Clinical Medicine, University of Oslo - Section for Clinical Immunology and Infectious Diseases and University of Oslo - Institute of Clinical Medicine
Downloads 330 (227,311)
Citation 5

Abstract:

Loading...

2.

Interleukin-6 Receptor Inhibition in Acute St-Segment Elevation Myocardial Infarction: A Randomised Placebo-Controlled Trial

Number of pages: 31 Posted: 24 Sep 2020
University of Oslo - Department of Cardiology, University of Oslo - Department of Cardiology, Trondheim University Hospital - Clinic of Cardiology, University of Oslo - Department of Cardiology, University of Oslo - Department of Cardiology, University of Oslo - Department of Cardiology, Trondheim University Hospital - Clinic of Cardiology, University of Oslo - Research Institute of Internal Medicine, Trondheim University Hospital - Clinic of Cardiology, Trondheim University Hospital - Department of Infectious Disease, University of Oslo - Department of Cardiology, University of Oslo - Department of Cardiology, University of Oslo - Department of Cardiology, University of Oslo - Division of Radiology and Nuclear Medicine, Trondheim University Hospital - Clinic of Cardiology, Norwegian University of Science and Technology (NTNU) - Department of Circulation and Medical Imaging, University of Oslo - Department of Cardiology, Trondheim University Hospital - Clinic of Cardiology, Trondheim University Hospital - Clinic of Cardiology, University of Oslo - Department of Cardiology, Trondheim University Hospital - Clinic of Cardiology, University of Oslo - Institute of Clinical Medicine and University of Oslo - Department of Cardiology
Downloads 85 (771,553)
Citation 2

Abstract:

Loading...

ST-elevation myocardial infarction; Reperfusion injury; Inflammation; Infarct size; Remodelling; Myocardial salvage, Randomized controlled trial; Interleukin-6 inhibitor